Presentazione markers cardiaci Uzbekistan
Upcoming SlideShare
Loading in...5
×
 

Presentazione markers cardiaci Uzbekistan

on

  • 471 views

 

Statistics

Views

Total Views
471
Views on SlideShare
471
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Presentazione markers cardiaci Uzbekistan Presentazione markers cardiaci Uzbekistan Presentation Transcript

  • CLINICO-ECONOMICAL IMPACT OF HTA IMPLEMENTATION ON CHEST PAIN DIAGNOSTIC MARKERS
    Dott. FilippoBartoccioni
    U.O. Clinical Governance
    S. Camillo – Forlanini Hospital
  • WHY AN HTA ON CHEST PAIN DIAGNOSTIC MARKERS PRESCRIPTION?
    TECHNOLOGY IMPROVEMENT GUIDELINE MODIFICATION
    MAIN DIAGNOSTIC MARKERS OF CHEST PAIN:
    TROPONIN I and T
    CK-MB
    MYOGLOBIN
  • METHODOLOGY OF TECHNOLOGY STUDY
    Technologies
    Yes,
    Itshouldbeused
    No Indication
    X3= note
    Clinical presentations
  • INTERVENTION OUTCOME GRAPHICS
  • CLINICAL IMPACT VERIFICATION THROUGH STATISTICAL ANALYSIS
    CONFIDENCE INTERVAL CONTAINS
    NUMBER ONE
    NULL HYPOTESIS IS CONFIRMED
    THERE IS NOT ANY DIFFERENCE BETWEEN BEFORE AND AFTER THE INTERVENTION
  • ECONOMICAL ANALYSIS
  • S. Camillo- Forlanini U.O. Formazione e Governo Clinico
    APPROPRIATENESS AND ECONOMICAL IMPACT
    We started from an average of about 1100 myoglobin / month / PS’ s tests.The intervention led to a required’s reduction amounts to 96.78%.
  • Thank you
    for your attention
    Contacts:
    nucleohta@gmail.com
    NucleoHTA